John Conti, MD

John Conti, MD

Oncology Montclair, NJ

Hematology/Oncology Physician at Essex Hematology/Oncology Group

Office Address

  • 1 Bay Avenue
    Suite 2
    Montclair, NJ 07042
    Phone: (973) 744-8000
    Fax: (973) 744-8340

John Conti, MD

Oncology Montclair, NJ

Hematology/Oncology Physician at Essex Hematology/Oncology Group

Clinical Specialties & Interests

  • Oncology: General Oncology
  • Clinical Interests: Hematology

Education & Training

  • Memorial Sloan-Kettering Cancer CenterMemorial Sloan-Kettering Cancer Center
  • UMDNJ-University HospitalUMDNJ-University Hospital
  • Rutgers New Jersey Medical SchoolRutgers New Jersey Medical School
  • Rutgers UniversityRutgers University

Certifications & Licensure

  • NY State Medical LicenseNY State Medical License1989 - 2016
  • NJ State Medical LicenseNJ State Medical LicenseActive through 2013
  • American Board of Internal MedicineInternal Medicine
  • American Board of Internal MedicineMedical Oncology
  • American Board of Internal MedicineHospice & Palliative Medicine

    Awards, Honors, & Recognition

    • Regional Top DoctorCastle Connolly, 2014
    • CMS Meaningful Use Stage 1 CertificationOncoEMR, Altos Solutions, Inc., 2012, 2013
    • Community Service AwardPaterson Federation Knights of Columbus Council, 2007

    Publications & Presentations


    Journal Articles

    • Hepatio Arterial Infusion of Chemotherapy after Resection of Hepatic Metastases from Colorectal Cancer.  Kemeny N, Huang Y, Cohen AM, Shi W, Conti JA, et al, N Engl J Med, 1/1/1999
    • Phase II Trial of Docetaxel (Taxotere) for Untreated Advanced Colorectal Carcinoma.  Clark TB, Kemeny NE, Conti JA, et al, Cancer Invest, 1/1/1998
    • Site Specific Study: Breast Cancer -DCIS.  Conti JA, Arani I, Mountainside Hospital Cancer Program Annual Report, 1/1/1998

    Books/Book Chapters

    • Cancer of the Colon, Rectum, and Anus Chapter: Metastatic Colorectal Cancer: Are There Prognostic Determinants. Page 769 - 781
      Conti JA, Kemeny N
      Editors: Cohen AM, Winawer SJ.McGraw-Hill, Inc., New York, NY.


    • Treatment with Gemcitabine (GEM) for Patients with Advanced Pancreatic Cancer in a Community Oncology Practice. Conti JA, Scoppetuolo M, Alter RS, et al, Clinical Cancer Research in NJ, 3/5/1997
    • Final Results of a Phase I Trial of Sequential Trimetrexate (TMTX), Fluorouracil (FU), and High Dose Leucovorin (LV) in Previously Treated Patients (Pts) with Gastroin... Conti JA, Kemeny NE, Tong W, Andre M, Bertino JR, Proc Am Soc Clin Oncol, 1/1/1997
    • Experience with Trimetrexate in GI Cancer. Conti JA, J Clin Invest Chemotherapy, 1/1/1995

    Insurance Accepted

    • Aetna Choice POS II
    • Aetna HMO
    • AmeriHealth Direct POS
    • AmeriHealth Direct POS Value Network
    • Amerihealth HMO
    • AmeriHealth HMO Value Network
    • AmeriHealth PPO
    • AmeriHealth PPO Value Network
    • BCBS Blue Card PPO
    • BCBS Illinois PPO
    • CIGNA Open Access
    • First Health PPO
    • GHI PPO
    • Great West PPO
    • HIP of New York - Select PPO
    • Horizon BCBS Direct Access
    • Horizon BCBS HMO
    • Horizon BCBS POS
    • Horizon BCBS PPO
    • Humana ChoiceCare Network PPO
    • MagnaCare PPO
    • Multiplan PHCS PPO
    • Multiplan PPO
    • Oxford Health Freedom
    • Oxford Health Liberty
    • QualCare HMO
    • QualCare PPO
    • United Healthcare - Direct Choice Plus POS
    • United Healthcare - Direct Options PPO
    • The full profile is locked and available to verified physicians only.
      Join over 60% of U.S. physicians already on Doximity and get access to this and over 700,000 physician CVs. Find your physician profile

    Physicians, view Dr. Conti's full Doximity profile to:

    • Trade HIPAA-secure messages
    • Send and receive online faxes
    • Refer a patient
    • See their complete CV